**Background:** Avian coccidiosis, caused by Eimeria spp., is a major parasitic disease in poultry leading to oxidative stress, inflammation, and economic losses. Conventional anticoccidial drugs face resistance issues, prompting interest in natural alternatives. Myricetin, a flavonoid with known antioxidant and anti-inflammatory properties, has not been previously evaluated against avian coccidiosis. This study aimed to assess the effects of dietary myricetin on growth performance, antioxidant status, immune modulation, and anticoccidial efficacy in broiler chickens challenged with Eimeria spp.
**Methods:** Five hundred one-day-old male Ross 308 chicks (initial BW 44.2 ± 0.2 g) were randomly divided into five groups (5 replicates of 10 birds each): negative control (NC, basal diet, no challenge), infected control (IC, basal diet, challenged), and three myricetin-supplemented groups (Myc 200, Myc 400, Myc 600) receiving 200, 400, or 600 mg myricetin/kg diet, respectively, and challenged. At 14 days of age, challenged birds were gavaged with a suspension of sporulated oocysts from E. tenella (5.0 × 10^3), E. maxima (7.0 × 10^3), and E. acervulina (3.5 × 10^4). Growth performance was monitored over 42 days. Fecal oocyst counts were measured at 7, 14, and 21 days post-infection (dpi). Intestinal lesion scores were assessed at 7 dpi. Serum biomarkers (NO, CRP, MPO, IgG) were measured pre-infection and at 14 and 21 dpi. Oxidative/antioxidant biomarkers (T-AOC, MDA, ROS, H2O2) were evaluated in muscle and intestinal tissues at 42 days. Gene expression of antioxidant (CAT, SOD, GSH-Px, HO-1, NQO1), inflammatory (COX-2, IL-6, IL-1β, TNF-α, IL-10), chemokine (CCL4, CCL20, CXCL13), and defensin (AvBD6, AvBD12) genes was analyzed by RT-qPCR.
**Key Results:** Myricetin supplementation dose-dependently improved growth performance. Overall (0–42 d), final BW was significantly higher in Myc 600 (2496.67 g) and Myc 400 (2459.67 g) vs. IC (2145.67 g, p < 0.001). Overall FCR was best in NC (1.64) and Myc 600 (1.63), worst in IC (1.92, p < 0.001). Fecal oocyst counts at 21 dpi were significantly reduced in Myc 600 (34.80 × 10^3/g) vs. IC (74.20 × 10^3/g, p < 0.001). Intestinal lesion scores at 7 dpi were significantly lower in Myc 600 (cecal score 2.20) vs. IC (3.60, p < 0.001). Mortality at 7 dpi was highest in IC (18.00%) and lowest in Myc 600 (7.40%, p < 0.001). Serum IgG at 21 dpi was highest in Myc 600 (8.64 mg/dL) vs. IC (6.40 mg/dL, p < 0.001), while CRP, NO, and MPO were significantly reduced by myricetin. In muscle tissues, MDA was lowest in Myc 600 (16.20 nmol/g) vs. IC (21.69 nmol/g, p < 0.001), and T-AOC was highest in Myc 600 (3.35 U/mg) vs. IC (1.62 U/mg, p < 0.001). Myricetin upregulated antioxidant gene expression (CAT, SOD, GSH-Px, HO-1, NQO1) and downregulated COX-2, proinflammatory cytokines (IL-1β, IL-6, TNF-α), and chemokines (CCL4, CCL20, CXCL13), while upregulating IL-10, AvBD6, and AvBD12 expression in a dose-dependent manner.
**Clinical Implications:** Dietary myricetin, particularly at 600 mg/kg, effectively alleviated the negative impacts of experimental Eimeria spp. infection in broiler chickens by improving growth performance, reducing oocyst shedding and intestinal lesions, lowering mortality, and enhancing antioxidant and anti-inflammatory responses. These findings support myricetin as a promising natural feed additive for controlling avian coccidiosis, offering an alternative to conventional anticoccidial drugs. Further research is needed to elucidate the precise mechanisms and evaluate practical applications in poultry farming.